Isis Pharmaceuticals Company Profile

Aggregated data from the web about Isis Pharmaceuticals

Company Name	Isis Pharmaceuticals
Website	https://www.isispharma.com
Snippet	IsisPharma uses cookies to measure the audience of the site and the content offered. IsisPharma also relies on third party services that store cookies in your terminal to enable you to interact on social networks and view videos directly on the site.
Type	Public company
Founded	1989
Founder	Stanley T. Crooke
Revenue	$1.122 billion (2019)
Website	www.ionispharma.com
Formerly	Isis Pharmaceuticals
Industry	Biotechnology
Products	nusinersen, inotersen, volanesorsen, plazomicin, mipomersen
Traded as	NASDAQ: IONSRussell 1000 Index component
Key people	Stanley T. Crooke, ChairmanBrett P. Monia, CEOElizabeth L. Hougen, CFO
Net income	$294 million (2019)
Headquarters	Carlsbad, California, United States
Total assets	$3.233 billion (2019)
Total equity	$1.684 billion (2019)
Number of employees	817 (2020)

Isis Pharmaceuticals is part of the United States company list

Isis Pharmaceuticals is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.